Author Correction: Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targeting

Affiliations

• ¹ Danish Cancer Institute, Copenhagen, Denmark.
• ² Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
• ³ Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
• ⁴ Computational Health Informatics Program, Boston Children's Hospital, Boston, MA, USA.
• ⁵ Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard University, Cambridge, MA, USA.
• ⁶ Division of Gastrointestinal Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
• ⁷ Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
• ⁸ Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary.
• ⁹ 2nd Department of Pathology, SE NAP, Brain Metastasis Research Group, Semmelweis University, Budapest, Hungary.
• ¹⁰ Department of Physics of Complex Systems, Eötvös Loránd University, Budapest, Hungary.
• ¹¹ Department of Medical Oncology, Center for Gastrointestinal Cancers, Yale Medical Center, New Haven, CT, USA.
• ¹² Caris Life Sciences, Phoenix, AZ, USA.
• ¹³ Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
• ¹⁴ Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
• ¹⁵ Center for DNA Damage and Repair (CDDR), Dana-Farber Cancer Institute, Boston, MA, USA.
• ¹⁶ Danish Cancer Institute, Copenhagen, Denmark. [email protected].
• ¹⁷ Computational Health Informatics Program, Boston Children's Hospital, Boston, MA, USA. [email protected].
• ¹⁸ Department of Bioinformatics and Department of Pathology, Forensic and Insurance Medicine, Semmelweis University, Budapest, Hungary. [email protected].
• ¹⁹ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. [email protected].
• ²⁰ Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. [email protected].
• ²¹ Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard University, Cambridge, MA, USA. [email protected].
• ²² Division of Gastrointestinal Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. [email protected].